Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury-Reference-Cited by-同舟云学术

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury

Published:2020-10-21 Issue:11 Volume:33 Page:2745-2748
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Gibson Andrew¹,Hammond Sean¹,Jaruthamsophon Kanoot¹,Roth Sharin²,Mosedale Merrie³^ORCID,Naisbitt Dean J.¹^ORCID

Affiliation:

1. MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.

2. Otsuka Pharmaceutical Development & Commercialization, Inc., Research Boulevard, Rockville, Maryland 20882, United States

3. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina 27599, United States

Funder

Medical Research Council

Otsuka Pharmaceutical Development & Commercialization

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.chemrestox.0c00328

Reference8 articles.

1. Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database

2. Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach

3. miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model

4. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury

5. Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Residence Time Peptide Antagonist for the Vasopressin V₂ Receptor to Treat Autosomal Dominant Polycystic Kidney Disease;Journal of Medicinal Chemistry;2024-03-20

2. Cascade Radical Trifluoromethylthiolation/Cyclization of Dienes To Access SCF₃-Containing Medium-Sized Heterocycles;Organic Letters;2023-06-12

3. Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions;Exploration of Digestive Diseases;2023-04-26

4. Activation of tolvaptan-responsive T-cell clones with the structurally-related mozavaptan;Toxicology Letters;2023-01

5. Pathology of drug hypersensitivity reactions and mechanisms of immune tolerance;Clinical & Experimental Allergy;2022-10-20